opipramol/nicotine (ND0801)
/ Tanabe Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 05, 2019
A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
(clinicaltrials.gov)
- P1/2; N=40; Completed; Sponsor: NeuroDerm Ltd.; Recruiting ➔ Completed
Clinical • Trial completion
1 to 1
Of
1
Go to page
1